Skip to main content
. 2011 Jun 15;12(6):4027–4052. doi: 10.3390/ijms12064027

Figure 1.

Figure 1

RNAi-Based Lead Identification Workflow. Aberrant expressed genes identified in the RNAi screen are categorized into clusters based on biological function. Members of the largest clusters are literature and database-mined for known small molecule modulators. Candidate inhibitors are subjected to biotesting for hit confirmation. This review focuses on the ability of bioinformatics methods to identify potential medicinal lead compounds.